🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients

Recruitingn/aAges any - 25 YearsAllSahlgrenska University Hospital
NCT07202910 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational (diagnostic validation) study is to validate imaging-based biomarkers for assessing liver involvement in pediatric patients with established or suspected liver disease. The projekt involves 3 larger studies, each with specific aims specified in detailed description below. The main study (study 1) compares imaging-based biomarkers-with liver biopsy to evaluate their correlation with histologically confirmed liver disease, including fibrosis, inflammation, and steatosis. The main question the overall project aims to answer is: • Can multiple novel imaging-based biomarkers, such as shear wave elastography (SWE), shear wave dispersion (SWD), and attenuation imaging (ATI), be used for detailed, non-invasive liver characterization in children, and if so, how should they be used?

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria (Study 1-main study) * all patients scheduled for a clinically liver biopsy at the Queen Silvia Children's Hospital * any form of suspected or confirmed liver disease * age between 0-18 years * consent by the child/parents to participate. * For controls: children scheduled for a renal biopsy * age between 0-18 years * consent by the child/parents to participate. Exclusion Criteria: * technical limitations regarding the measurements * inability to fully understand the informed consent documents.
💊

What it tests

  • Not listed
📍

Where

1 site
Department of Radiology, Queen Silvias Children´s Hospital,Gothenburg Sweden
Gothenburg, Sweden
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy